JP2022504153A5 - - Google Patents
Info
- Publication number
- JP2022504153A5 JP2022504153A5 JP2021518432A JP2021518432A JP2022504153A5 JP 2022504153 A5 JP2022504153 A5 JP 2022504153A5 JP 2021518432 A JP2021518432 A JP 2021518432A JP 2021518432 A JP2021518432 A JP 2021518432A JP 2022504153 A5 JP2022504153 A5 JP 2022504153A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- egf
- gaqp
- desb30
- gglu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18198892 | 2018-10-05 | ||
| EP18198892.4 | 2018-10-05 | ||
| PCT/EP2019/076889 WO2020070276A1 (en) | 2018-10-05 | 2019-10-04 | Bifunctional compounds comprising insulin peptides and egf(a) peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504153A JP2022504153A (ja) | 2022-01-13 |
| JP2022504153A5 true JP2022504153A5 (cg-RX-API-DMAC10.html) | 2022-10-12 |
| JP7434299B2 JP7434299B2 (ja) | 2024-02-20 |
Family
ID=64017248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518432A Active JP7434299B2 (ja) | 2018-10-05 | 2019-10-04 | インスリンペプチドおよびｅｇｆ（ａ）ペプチドを含む二官能性化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11649269B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3861017A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7434299B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN112789289A (cg-RX-API-DMAC10.html) |
| AR (1) | AR116605A1 (cg-RX-API-DMAC10.html) |
| MA (1) | MA53809A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202028229A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020070276A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939605A1 (en) | 2016-12-09 | 2022-01-19 | Akston Biosciences Corporation | Insulin-fc fusions and methods of use |
| US11267862B2 (en) | 2018-06-29 | 2022-03-08 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| HUE062719T2 (hu) | 2018-06-29 | 2023-11-28 | Akston Biosciences Corp | Ultra-hosszú hatású inzulin-FC fúziós fehérjék és az alkalmazási eljárások |
| KR102865175B1 (ko) | 2019-12-19 | 2025-09-30 | 악스톤 바이오사이언시스 코퍼레이션 | 초-장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| LT3972987T (lt) | 2020-04-10 | 2023-09-25 | Akston Biosciences Corporation | Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| CA3193453A1 (en) | 2020-09-30 | 2022-04-07 | Beijing Ql Biopharmaceutical Co., Ltd. | Polypeptide conjugates and methods of uses |
| US11667689B2 (en) | 2021-07-23 | 2023-06-06 | Akston Biosciences Corporation | Insulin-Fc fusion proteins and methods of use to treat cancer |
| EP4323413A4 (en) | 2022-03-30 | 2025-10-15 | Beijing Ql Biopharmaceutical Co Ltd | LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF |
| CN115850385B (zh) * | 2022-07-04 | 2023-08-11 | 北京惠之衡生物科技有限公司 | 一种促表达肽及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009022006A1 (en) | 2007-08-15 | 2009-02-19 | Novo Nordisk A/S | Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
| HUE032284T2 (en) | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| EP2296694B1 (en) | 2008-04-23 | 2015-08-05 | Amgen Inc. | Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof |
| GB201005005D0 (en) | 2010-03-25 | 2010-05-12 | Angeletti P Ist Richerche Bio | New vaccine |
| KR20140041747A (ko) | 2011-06-20 | 2014-04-04 | 제넨테크, 인크. | Pcsk9-결합 폴리펩티드 및 사용 방법 |
| BR112016017402A2 (pt) | 2014-02-21 | 2017-10-17 | Medimmune Ltd | fusões anti-pcsk9~glp-1 e métodos para uso |
| CN104558199B (zh) | 2014-09-05 | 2018-07-06 | 成都康弘生物科技有限公司 | 一种治疗高胆固醇血症的融合蛋白制备及其用途 |
| WO2016164762A1 (en) | 2015-04-08 | 2016-10-13 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same |
| BR112018002416A2 (pt) | 2015-08-25 | 2018-09-18 | Novo Nordisk As | derivados de insulina e seus usos médicos |
| RU2747877C2 (ru) | 2016-01-13 | 2021-05-17 | Ново Нордиск А/С | Аналоги эфр(а) с заместителями - жирными кислотами |
-
2019
- 2019-10-04 EP EP19783295.9A patent/EP3861017A1/en not_active Withdrawn
- 2019-10-04 MA MA053809A patent/MA53809A/fr unknown
- 2019-10-04 CN CN201980064514.4A patent/CN112789289A/zh not_active Withdrawn
- 2019-10-04 TW TW108135986A patent/TW202028229A/zh unknown
- 2019-10-04 JP JP2021518432A patent/JP7434299B2/ja active Active
- 2019-10-04 WO PCT/EP2019/076889 patent/WO2020070276A1/en not_active Ceased
- 2019-10-04 AR ARP190102838A patent/AR116605A1/es unknown
- 2019-10-04 US US17/281,813 patent/US11649269B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8138144B2 (en) | Antimicrobial cationic peptides and formulations thereof | |
| CN103596583B (zh) | 新型胰高血糖素类似物 | |
| US9180159B2 (en) | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases | |
| JP2012506402A5 (cg-RX-API-DMAC10.html) | ||
| CN114901682A (zh) | 胰岛素衍生物 | |
| CN104159597A (zh) | 用于预防或治疗非酒精性脂肪肝疾病的药学组合物 | |
| IL277483B1 (en) | New anti-GLP-1 analogs | |
| RU2008141280A (ru) | Агонисты рецептора нейромедина u и их применение | |
| KR20060073584A (ko) | 아미노산 프로드럭 | |
| JP2005530732A5 (cg-RX-API-DMAC10.html) | ||
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| CA3073011C (en) | Acylated oxyntomodulin peptide analog | |
| JP2017071609A (ja) | オキシントモジュリンと免疫グロブリン断片とを含む結合体及びその用途 | |
| KR20260028831A (ko) | Glp-1/gip/글루카곤 수용체를 활성화시키는 알부민 결합 거대분자 삼중효능제 및 이를 위한 방법 | |
| JP2025525217A (ja) | グルカゴン様ペプチド－１受容体アンタゴニスト | |
| JP5647609B2 (ja) | 経粘膜吸収性を付与したモチリン類似ペプチド化合物 | |
| WO2015180634A1 (zh) | 用于治疗2型糖尿病的长效肠激素多肽类似物及应用 | |
| JP2016526533A (ja) | アミリンミメティック化合物とポリエチレングリコールの非凝集バイオ接合体 | |
| JP2023508349A (ja) | グルカゴン受容体およびｇｌｐ－１受容体のステープルトリアゾールコアゴニスト | |
| US20250059232A1 (en) | Pentapeptide and use thereof | |
| EP1372733B1 (en) | Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration | |
| JP2024527220A5 (cg-RX-API-DMAC10.html) | ||
| BRPI0619641A2 (pt) | peptìdeo cìclico ou variante do mesmo, processo para a preparação de um peptìdeo, peptìdeo ciclizado, composição, uso de um peptìdeo cìclico ou variante do mesmo, e, método para tratar ou previnir uma infecção microbiana em um indivìduo | |
| WO1999065512A1 (fr) | Compositions medicinales contenant des peptides apparentes au facteur de croissance des fibroblastes | |
| KR20190138065A (ko) | 지방산 항균펩타이드 및 이를 함유하는 항균 조성물 |